View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Psoriatic Arthritis News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 09, 2021
3 min read
Save

Arthritis among most common chronic conditions for US veterans

Arthritis among most common chronic conditions for US veterans

Arthritis and hypertension are the two most prevalent chronic conditions among U.S. veterans aged 25 years and older, according to data published by CDC researchers in National Health Statistics Report.

SPONSORED CONTENT
March 08, 2021
2 min watch
Save

VIDEO: Meeting to address undertreatment of CVD in patients with psoriatic disease

VIDEO: Meeting to address undertreatment of CVD in patients with psoriatic disease

Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania, discusses an upcoming program from the National Heart, Lung, and Blood Institute.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
March 03, 2021
2 min read
Save

Two-year delay in diagnosis common for patients with psoriatic arthritis

Two-year delay in diagnosis common for patients with psoriatic arthritis

More than half of patients with psoriatic arthritis experience a two-year delay from symptom onset to diagnosis, especially younger patients, those who are obese and those with enthesitis, noted data published in The Journal of Rheumatology.

SPONSORED CONTENT
March 02, 2021
2 min read
Save

Heart failure linked to disease activity, inflammation in patients with psoriatic disease

Heart failure linked to disease activity, inflammation in patients with psoriatic disease

Systemic inflammation burden and disease activity are independent risk factors for heart failure among patients with psoriatic disease, according to data published in Arthritis Care & Research.

SPONSORED CONTENT
March 01, 2021
1 min read
Save

Poor cardiorespiratory fitness early in life may predict psoriatic disease in men

Men with poor cardiorespiratory fitness levels during late adolescence were more likely to develop psoriasis or psoriatic arthritis later in life, according to a study.

SPONSORED CONTENT
February 25, 2021
2 min read
Save

FDA expands Simponi Aria labeling to include fatigue in RA, PsA

FDA expands Simponi Aria labeling to include fatigue in RA, PsA

The FDA has approved a label update for Janssen’s golimumab to include language that treatment alongside methotrexate improves fatigue in patients with active psoriatic arthritis and moderately to severely active rheumatoid arthritis.

SPONSORED CONTENT
February 22, 2021
2 min read
Save

Ixekizumab effective in psoriatic arthritis up to 1 year regardless of methotrexate use

Ixekizumab effective in psoriatic arthritis up to 1 year regardless of methotrexate use

Ixekizumab is efficacious in patients with psoriatic arthritis for up to 1 year, with or without concomitant methotrexate use, according to data published in Arthritis Research & Therapy.

SPONSORED CONTENT
February 22, 2021
2 min read
Save

Moderate, high rheumatic disease activity linked to higher risk for COVID-related death

Moderate, high rheumatic disease activity linked to higher risk for COVID-related death

Moderate and high disease activity, as well as the use of immunosuppressants, were associated with a higher risk for COVID-related death in patients with rheumatic diseases, according to data in the Annals of the Rheumatic Diseases.

SPONSORED CONTENT
February 16, 2021
10 min read
Save

'We need to see the data': FDA's Xeljanz safety warning stirs concerns for JAK inhibitors

'We need to see the data': FDA's Xeljanz safety warning stirs concerns for JAK inhibitors

For Pfizer and its JAK inhibitor, Xeljanz, February rang in with the sound of alarm bells, as the FDA issued its third warning about the drug in 2 years.

SPONSORED CONTENT
February 15, 2021
3 min read
Save

Checkpoint inhibitor response, adverse event rate similar regardless of autoimmune disease

Checkpoint inhibitor response, adverse event rate similar regardless of autoimmune disease

Patients’ response to anti-CTLA-4 or anti-PD-1 checkpoint therapy for advanced melanoma, and their incidence of immune-related adverse events of grade 3 or higher, were similar regardless of preexisting autoimmune disease, according to data.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails